4.20
+0.01(+0.24%)
Currency In USD
| Previous Close | 4.19 |
| Open | 4.15 |
| Day High | 4.24 |
| Day Low | 4 |
| 52-Week High | 7.54 |
| 52-Week Low | 3.93 |
| Volume | 2.61M |
| Average Volume | 1.15M |
| Market Cap | 215.37M |
| PE | 6.56 |
| EPS | 0.64 |
| Moving Average 50 Days | 5.58 |
| Moving Average 200 Days | 5.77 |
| Change | 0.01 |
If you invested $1000 in Abeona Therapeutics Inc. (ABEO) 10 years ago, it would be worth $37.42 as of November 10, 2025 at a share price of $4.2. Whereas If you bought $1000 worth of Abeona Therapeutics Inc. (ABEO) shares 5 years ago, it would be worth $146.09 as of November 10, 2025 at a share price of $4.2.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Abeona Therapeutics® Announces Date of Third Quarter Financial Results and Upcoming Investor Conference Participation
GlobeNewswire Inc.
Nov 07, 2025 12:30 PM GMT
CLEVELAND, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it will host a conference call on Wednesday, November 12, 2025 at 8:30 a.m. ET to discuss its third quarter 2025 financial results and corporate pr
Abeona Therapeutics® Announces Permanent J-Code for ZEVASKYN® (prademagene zamikeracel)
GlobeNewswire Inc.
Oct 30, 2025 2:45 PM GMT
CLEVELAND, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a commercial-stage biopharmaceutical company developing cell and gene therapies for serious diseases, today announced that the Centers for Medicare and Medicaid S
Abeona Therapeutics® Appoints James A. Gow, MD, MBA, MS, MHCM, as Senior Vice President, Head of Clinical Development & Medical Affairs
GlobeNewswire Inc.
Oct 20, 2025 12:30 PM GMT
CLEVELAND, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a commercial-stage biopharmaceutical company developing cell and gene therapies for serious diseases, today announced the appointment of James A. Gow, MD, MBA, MS